10 GE Xenokidney for kidney failure, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Mar 2025: Trial registered, NCT06878560
  2. 29 Oct 2025: Trial started, NCT06878560

The trials

NCT06878560: Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

State
Under way
Phase
Phase 1 and Phase 2
People
50 planned
Started
29 Oct 2025
Primary completion
Oct 2028
Arms
10 GE Xenokidney
Results
None posted
  1. 17 Mar 2025: Trial registered
  2. 29 Oct 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.